Using next-generation sequencing, the UPSeq test assesses 15 biomarkers to find aggressive prostate cancer that can be missed by biopsies or imaging tests.
MiTF renal cell carcinoma can masquerade as other subtypes and may not respond as well to front-line therapies.
Clinical guidelines have encouraged the integration of palliative care, yet medicine lags far behind its goals for ovarian cancer, especially for people of color.
A urologic oncology fellow dedicates his career to debunking false notions about racial biology.
U-M study combines local data with data from The Cancer Genome Atlas to discover novel biomarkers for chromophobe renal cell carcinoma through next-generation RNA sequencing.
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.